Skip to content
Screener

Donaldson Company DCI Life Sciences Segment — Net Sales

Other segment segments

Mobile Solutions Segment
$629.9M+8.1%
Industrial Solutions Segment
$281.7M-0.6%

Similar metrics at other companies

Materion logo
MTRNLife sciences — Net Sales
$13.22M-5.9%
Bio-Rad Laboratories logo
BIOLife Science — Net Sales
$228.5M0.0%
GLW
GLWLife Science Products — Net Sales
$249M+1.2%
Commercial Metals logo
CMCSegment Eliminations — Net Sales
-$33.65M-10.8%
The Kraft Heinz Company logo
KHCEmerging Markets Segment — Net Sales
$704.25M+1.8%
IDEX logo
IEXHealth & Science Technologies — Net Sales
$415M+13.6%

Other financials

Income statement

See full
Revenue$995.1M+5.9%
Gross profit$333.4M+3.6%
Operating income$155.3M+77.7%
Net income$118.1M+104%
EPS (diluted)$1.00+108%

Balance sheet

See full
Cash & equivalents$204.1M+14.3%
Total debt$601.9M-16.7%
Total equity$1.7B+15.8%
Total assets$3.1B+3.0%

Cash flow

See full
Operating cash flow$135.4M+54.4%
CapEx$23.3M+42.9%
Free cash flow$112.1M+57.0%

Valuation

See full
Market cap$11.27B+34.1%
Enterprise value$11.67B+30.4%
P/E25.7×+2.8×
P/S+0.7×

Profitability

See full
Gross margin34.2%-1.0pp
Operating margin15.1%+1.7pp
Net margin11.5%+1.6pp
FCF margin10.3%+2.1pp

Returns & leverage

See full
Return on equity27.8%+3.2pp
Debt / equity0.4×-0.1×
Current ratio2.4×+0.4×

Where this comes from

Reported directly by Donaldson Company in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.

The source filing: Donaldson Company’s 10-Q, filed June 2, 2026.

Filed
Jun 2, 2026, 11:28 AM EDT
Fiscal quarter
Q3 FY2026
Calendar quarter
Q2 2026
Accession
0000029644-26-000052
Three Months Ended April 30, 2026Mobile Solutions SegmentIndustrial Solutions SegmentLife Sciences SegmentTotal SegmentCorporate and Unallocated (1)Total Company
Net sales$629.9$281.7$83.5$995.1$995.1
Cost of sales422.6179.249.2
Other segment items (2)80.364.827.5
Earnings (loss) before income taxes$127.0$37.7$6.8$171.5$(16.7)$154.8
Equity earnings in unconsolidated affiliates$3.5$3.5
Nine Months Ended April 30, 2026
Net sales$1,784.8$799.2$242.8$2,826.8$2,826.8
Cost of sales1,202.7503.0140.4

Item 1. Financial Statements

FAQ

What is Donaldson Company's life sciences segment — net sales?
Donaldson Company (DCI) reported life sciences segment — net sales of $83.5M in Q1 2026.
How has Donaldson Company's life sciences segment — net sales changed year-over-year?
Donaldson Company's life sciences segment — net sales increased by 12.5% year-over-year, from $74.2M to $83.5M.
What is the long-term trend for Donaldson Company's life sciences segment — net sales?
Over 4 years (2021 to 2025), Donaldson Company's life sciences segment — net sales has grown at a 3.8% compound annual growth rate (CAGR), from $254.5M to $295.6M.
What does life sciences segment — net sales mean?
The total revenue generated from the sale of filtration products and services within the Life Sciences segment, net of returns, allowances, and discounts. This is the primary indicator of the segment's market demand and top-line growth.

Ask your AI about Donaldson Company's life sciences segment — net sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude